OBI Pharma announces COVID-19 vaccine clinical trials to start in 2022
02/08/2022 08:38 PM
Taiwan-based biotech firm OBI Pharma Inc. announced Tuesday that the COVID-19 vaccine it developed called BCVax will enter phase 1 & 2 clinical trials in the second half of this year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
'Judo Heartthrob' settles for silver at Asian Championships
04/20/2024 09:38 PM - Cross-Strait
Faced with China flight path moves, Taiwan to stay the course: Source
04/20/2024 09:21 PM - Culture
Taiwan presents 'Everyday War' exhibition at Venice Biennale
04/20/2024 07:08 PM - Society
Migrant fishers' rights deal takes force after over 1 year in limbo
04/20/2024 06:34 PM - Politics